Match each prenatal screening test or prophylactic intervention with its appropriate clinical indication and temporal timing during an uncomplicated pregnancy.
- Syphilis, HIV, and Hepatitis B screeningUniversally recommended at the initial prenatal visit for all pregnant patients.
- Chlamydia and Gonorrhea screeningRecommended at the initial prenatal visit specifically for patients under 25 years of age or those with recognized high-risk behaviors.
- Early 50-g oral glucose challenge testRecommended at the initial prenatal visit specifically for patients with risk factors for pregestational diabetes.
- Administration of Tdap vaccineUniversally recommended during every pregnancy, optimally between 27 and 36 weeks of gestation.
Cevap
Syphilis, HIV, and Hepatitis B screening is universally recommended at the initial visit. Chlamydia and Gonorrhea screening is indicated at the initial visit for patients <25 or those who are high-risk. Early glucose screening is for patients with pregestational diabetes risk factors. The Tdap vaccine is universally recommended between 27 and 36 weeks.
The established standard of prenatal care requires stratifying interventions by gestational age and patient risk profile. Syphilis, HIV, and Hep B are universal initial screens. Chlamydia/Gonorrhea and early GCT are initial screens reserved for specific risk groups. Finally, Tdap is a universal intervention delayed until 27-36 weeks to optimize neonatal immunity.
Adım Adım Çözüm
Anahtar Kavram
Routine prenatal care involves a combination of universal infectious disease screening at the initial visit, targeted risk-based screening for specific populations, and temporally optimized prophylactic interventions such as the Tdap vaccine in the late second or third trimester.